Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Deakin University | OTHER |
Not provided
Not provided
Not provided
Not provided
The study is a pilot study (Total N=30), with at pre, weekly during treatment, post and at three-month follow-up.
Recruitment will be done through online advertisement via social media and gambling-related websites. Participants will self-referred to the study via a study dedicated website (www.spelstudien.se). Login to a treatment platform will be verified using double authentication (detailed description of the online platform is provided in the application to the Swedish Ethical Review Authority). Written information about the study will be provided on the web page. Consent will be done online, with the possibility for participants to download study information and consent. Consenting participants will start a screening procedure. After screening, participants will be contacted for a telephone assessment with a clinical psychologist. During this interview, participants will be assessed for GD with a diagnostic interview, as well as the inclusion criteria for utilization of "Spelpaus".
If meeting criteria for the study, participants will be referred to the baseline/ pre-measures - which will start with an additional informed consent for the treatment phase and the iCBT. Inclusion will be done after the completion of the informed consent and baseline/pre-measures. After that, participant will get access to the iCBT.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Internet-based iCBT targeting Gambling Disorder and comorbidities | Experimental | An 8 module internet-based iCBT program targeting Gambling Disorder and comorbidities, administered with treatment support. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| iCBT for Gambling Disorder and psychiatric comorbidities | Behavioral | The iCBT, is based on the gambling pathways model. As a clinical conceptualization, the treatment build on loss of control, but also include additional interventions (e.g., emotion regulation and impulse control) targeting the etiological co-morbidity factors in the pathways model for emotionally vulnerable and impulsive gamblers (pathways subtypes 2 and 3). |
| Measure | Description | Time Frame |
|---|---|---|
| The Gambling Symptom Assessment Scale | Primary outcome will be gambling symptoms, measured with the the Gambling Symptom Assessment Scale. Minimum score is 0 and maximum score is 48, with higher scores indicated higher frequency of gambling symptoms. | Six months after treatment cessation |
| Measure | Description | Time Frame |
|---|---|---|
| The TimeLine Followback for gambling | Gambling behavior (days per week gambled) will be measured with a self-report item adapted from the TimeLine Followback for gambling. | Six months after treatment cessation |
| The Generalized Anxiety Disorder 7-itemscale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Olof Molander | Contact | 0700011241 | olof.molander@ki.se |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre for psychiatry research | Recruiting | Stockholm | 116 30 | Sweden |
Not provided
| ID | Term |
|---|---|
| D005715 | Gambling |
| ID | Term |
|---|---|
| D012309 | Risk-Taking |
| D001519 | Behavior |
| D007174 | Disruptive, Impulse Control, and Conduct Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Anxiety symptoms will be measured by the Generalized Anxiety Disorder 7-itemscale. |
| Six months after treatment cessation |
| The Patient Health Questionnaire | Depressive symptoms will be measured with the The Patient Health Questionnaire. | Six months after treatment cessation |
| The Alcohol Use Disorders Identification Test | Alcohol problems will be measured with the Alcohol Use Disorders Identification Test. | Six months after treatment cessation |
| The Drug Use Disorders Identification Test | Drug problems will be measured with the Drug Use Disorders Identification Test. | Six months after treatment cessation |